Trial NCT00324831

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000466677
Secondary IDs: FAV-ID-11 FAV-WIRB-20051774

Last trial update was posted on 2013-12-18

MeSH Interventions

Antibodies Antibodies, Monoclonal Cyclophosphamide Doxorubicin Immunoglobulin Idiotypes Immunoglobulins Immunomodulating Agents Liposomal doxorubicin Prednisone Rituximab Sargramostim Vaccines Vincristine

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID